$160 million ‘moonshot’ backs Boston effort to revolutionize rare disease treatment
A new $160 million non-profit initiative in Boston aims to accelerate the development of genetic therapies for rare and ultra-rare diseases.
Where it stands
The Broad Institute, Boston Children’s Hospital, and The Jackson Laboratory have launched the Center for Therapeutic Genetics. This collaborative effort focuses on creating personalized genetic medicines for conditions that currently lack treatment options.
Coverage from outlets including The Boston Globe, The New York Times, and Yahoo Finance highlights the $160 million funding backing this 'moonshot' project. Reports from Precision Medicine Online and Fierce Biotech emphasize the consortium's goal of scaling gene therapy development to address rare medical needs.
Observers are watching how the new center will structure its non-profit model to bridge the gap in therapeutic research. Future updates will likely clarify the timeline for initial development projects as the consortium begins its operations.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.
Who reported it (6)
- Broad Institute, Boston Children's Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseases Yahoo Finance · 46d ago
- New England Consortium Takes Aim at Scaling Gene Therapy Development Precision Medicine Online · 46d ago
- Gene therapy: changing the future for people with rare diseases wellcome.org · 46d ago
- ‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That The New York Times · 46d ago
- $160 million ‘moonshot’ backs Boston effort to revolutionize rare disease treatment The Boston Globe · 46d ago
- New center launches for personalized genetic therapies Fierce Biotech · 46d ago
Answered
What organizations are involved in the Center for Therapeutic Genetics?
The effort involves the Broad Institute, Boston Children's Hospital, and The Jackson Laboratory.
What is the stated goal of the new center?
The center aims to develop personalized genetic medicines for rare and ultra-rare diseases.
How much funding is backing this effort?
The initiative is backed by $160 million.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Scientists Can Now Spot Alzheimer’s 10 Years Before Symptoms
Diagnostic advancements in blood-based testing are shifting the Alzheimer's detection timeline, enabling the identification of risks years before symptoms.
Scientists find compound that may help muscles stay strong as we age
Researchers have identified a novel molecule that shows potential in reversing or slowing age-related muscle decline.
Breathalyser can tell if you are burning fat from a single exhalation
New sensor technology allows users to detect when their body shifts into fat-burning mode through a single exhalation.
Red Sox's Historic Win Streak Snapped After Tying Franchise Record, Latest Box Scores and Highlights
The Boston Red Sox's 15-game winning streak has concluded, stopping just one victory shy of establishing a new franchise record.
Engineered enzyme erases a stubborn mark of aging by up to 70% in human tissue samples
Researchers have engineered an enzyme capable of reversing a chemical marker of aging in human tissue samples by as much as 70%.
Rainout puts Red Sox’ chance to tie franchise-record 15-game winning streak on hold
The Boston Red Sox have halted their pursuit of a new franchise record after a 15-game winning streak came to an end against the Baltimore Orioles.